Total Payments
$13,565
2024 Payments
$7,325
Companies
58
Transactions
692
Medicare Patients
2,464
Medicare Billing
$234,170
Payment Breakdown by Category
Food & Beverage$13,008 (95.9%)
Education$281.30 (2.1%)
Consulting$275.00 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,008 | 686 | 95.9% |
| Education | $281.30 | 4 | 2.1% |
| Consulting Fee | $275.00 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,011 | 43 | $0 (2024) |
| ABBVIE INC. | $941.30 | 69 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $921.11 | 35 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $693.64 | 37 | $0 (2024) |
| Biogen, Inc. | $650.89 | 19 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $643.54 | 30 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $542.10 | 30 | $0 (2024) |
| Eisai Inc. | $533.63 | 19 | $0 (2024) |
| SK Life Science, Inc. | $514.79 | 41 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $509.17 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,325 | 355 | UCB, Inc. ($728.08) |
| 2023 | $4,024 | 225 | AbbVie Inc. ($343.69) |
| 2022 | $1,486 | 90 | IMPEL PHARMACEUTICALS INC. ($314.64) |
| 2021 | $422.80 | 18 | Biogen, Inc. ($123.61) |
| 2019 | $150.00 | 1 | Biogen, Inc. ($150.00) |
| 2018 | $32.07 | 2 | UCB, Inc. ($17.19) |
| 2017 | $125.00 | 1 | Biogen, Inc. ($125.00) |
All Payment Transactions
692 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Immunology | ||||||
| 12/20/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.48 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Central Nervous System | ||||||
| 12/17/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $6.62 | General |
| Category: Narcoplepsy | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $9.58 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $120.74 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Neurology | ||||||
| 12/03/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Immunology | ||||||
| 11/27/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $3.99 | General |
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Neuropsychiatry | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Rare Disease | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Rare Disease | ||||||
| 11/20/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.29 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 603 | 6,537 | $344,726 | $58,919 |
| 2022 | 9 | 407 | 4,252 | $207,279 | $40,461 |
| 2021 | 13 | 537 | 5,525 | $170,024 | $64,439 |
| 2020 | 18 | 917 | 1,141 | $171,369 | $70,351 |
Total Patients
2,464
Total Services
17,455
Medicare Billing
$234,170
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 168 | 247 | $55,132 | $14,888 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 98 | 98 | $40,376 | $11,478 | 28.4% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 58 | 60 | $99,300 | $7,937 | 8.0% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 52 | 52 | $43,680 | $4,498 | 10.3% |
| 72156 | Mri scan of upper spinal canal before and after contrast | Office | 2023 | 23 | 23 | $15,640 | $3,600 | 23.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 33 | 45 | $10,170 | $3,238 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 38 | $12,008 | $3,149 | 26.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 14 | 14 | $7,798 | $2,243 | 28.8% |
| 70544 | Mri scan of blood vessels of head without contrast | Office | 2023 | 20 | 21 | $19,887 | $2,185 | 11.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $6,979 | $1,884 | 27.0% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 63 | 5,900 | $17,700 | $1,555 | 8.8% |
| 70547 | Mri scan of blood vessels of neck without contrast | Office | 2023 | 12 | 12 | $11,376 | $1,134 | 10.0% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 13 | 13 | $4,680 | $1,130 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 82 | 82 | $33,784 | $9,363 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 141 | $31,443 | $8,339 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 64 | $20,224 | $5,902 | 29.2% |
| 70553 | Mri scan of brain before and after contrast | Office | 2022 | 32 | 33 | $54,615 | $4,471 | 8.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 30 | 42 | $9,198 | $3,223 | 35.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 20 | 20 | $11,140 | $2,935 | 26.4% |
| 70551 | Mri scan of brain without contrast | Office | 2022 | 30 | 30 | $25,200 | $2,927 | 11.6% |
| 72156 | Mri scan of upper spinal canal before and after contrast | Office | 2022 | 15 | 15 | $10,200 | $2,325 | 22.8% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2022 | 43 | 3,825 | $11,475 | $975.80 | 8.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 11 | 4,960 | $64,480 | $23,897 | 37.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 106 | 106 | $34,740 | $12,421 | 35.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 141 | 163 | $19,645 | $9,537 | 48.5% |
About Dr. Brian Averell, DO
Dr. Brian Averell, DO is a Neurology healthcare provider based in Akron, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891742763.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Averell, DO has received a total of $13,565 in payments from pharmaceutical and medical device companies, with $7,325 received in 2024. These payments were reported across 692 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($13,008).
As a Medicare-enrolled provider, Averell has provided services to 2,464 Medicare beneficiaries, totaling 17,455 services with total Medicare billing of $234,170. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Akron, OH
- Active Since 05/27/2006
- Last Updated 08/24/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1891742763
Products in Payments
- ULTOMIRIS (Biological) $816.20
- WAKIX (Drug) $643.54
- Briviact (Drug) $598.53
- XYWAV (Drug) $585.28
- KESIMPTA (Drug) $509.17
- NUPLAZID (Drug) $486.59
- UBRELVY (Drug) $471.72
- Leqembi (Drug) $433.49
- QULIPTA (Drug) $402.59
- Austedo XR (Drug) $402.22
- INSPIRE (Device) $334.73
- Trudhesa (Drug) $314.64
- TYSABRI (Biological) $312.36
- NURTEC ODT (Drug) $282.00
- REXULTI (Drug) $271.58
- Nayzilam (Drug) $244.80
- KISUNLA (Drug) $237.81
- VYEPTI (Biological) $214.03
- ACTHAR (Biological) $196.13
- BRIUMVI (Drug) $193.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Akron
Lawrence Saltis, Md, MD
Neurology — Payments: $35,752
Neurology $35,752
Hugh Miller, Md, MD
Neurology — Payments: $25,437
Neurology $25,437
Roswell Dorsett, Do, DO
Neurology — Payments: $7,666
Neurology $7,666
Alexander Venizelos, Md, MD
Neurology — Payments: $4,727
Neurology $4,727
Diana Slawski, Md, MD
Neurology — Payments: $4,176
Neurology $4,176
Susana Bowling, Md, MD
Neurology — Payments: $3,607
Neurology $3,607